BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3875181)

  • 1. [Dynamic sampling analysis of the immune status of breast cancer patients].
    Eremina OF; Kunitsyna TA; Sharonina AI
    Vopr Onkol; 1985; 31(6):33-7. PubMed ID: 3875181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional activity of the regional lymph nodes in breast cancer patients].
    Loboda VI; Grinevich IuA
    Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
    Fedin IuV; Ermilova VD
    Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal and immunological changes in breast cancers with different growth rates].
    Balmukhanov SB; Zhalgasbaeva GT; Kurralasov AK; Baisheva SA; Togaĭbaeva ZI
    Vopr Onkol; 1989; 35(11):1319-22. PubMed ID: 2609521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
    Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
    Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
    Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
    Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of the immune system in benign lesions and cancer of the breast].
    Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
    Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
    Nowak JS; Lanzrein C
    Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
    Kupin VI; Polevaia EB
    Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial immunologic evaluations in breast and thyroid cancer].
    Abeatici S; Mussa A; Levis P; Sandrucci S; Storta P
    Minerva Med; 1982 Apr; 73(18):1149-54. PubMed ID: 6979010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte count in the blood of stomach cancer patients].
    Volodarskiĭ VL; Maslova MG; Gurina LI; Dybova TV
    Vestn Khir Im I I Grek; 1981 Feb; 126(2):23-7. PubMed ID: 6972117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence in breast cancer. Analysis with frailty model.
    Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
    Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY; Staren ED; Tereshkova N; Braun DP
    J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival impact of integrative cancer care in advanced metastatic breast cancer.
    Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
    Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tree-based model for breast cancer prognostication.
    Banerjee M; George J; Song EY; Roy A; Hryniuk W
    J Clin Oncol; 2004 Jul; 22(13):2567-75. PubMed ID: 15226324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.